Allergy, Asthma and Immunology

A blog that publishes updates and open access scientific papers about allergy, asthma and immunology. Editor: Juan Carlos Ivancevich, MD. Specialist in Allergy & Immunology

Menu

Home
Allergy OA
Dermatology OA
Otorhinolaryngology OA
Pediatrics OA
Respiratory Medicine OA
Contact

June 9, 2011

Omalizumab is an effective treatment option for patients with CU with IgE autoantibodies against thyroperoxidase http://bit.ly/kdwIif

Publicado por ivancev@gmail.com en 8:18 AM

Email This BlogThis!Share to X Share to Facebook Share to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home

Subscribe to: Post Comments (Atom)

Newsletter

Get new posts by email:

Search This Blog

Translations

ORCID Juan C. Ivancevich

https://orcid.org/0000-0001-8713-6258

Blog Archive

Popular posts

Systemic Therapy for Atopic Dermatitis: Choosing Biologics or Janus Kinase Inhibitors for Children and Adults

Scholl IM, Drucker AM, Flohr C, Gerbens LAA. J Allergy Clin Immunol Pract. 2026 Feb;14(2):344-359. doi: 10.1016/j.jaip.2025.10.052. Abstrac...
Desensitisation to cow’s milk, following partially or extensively hydrolysed formulae feeding regimens, in infants with allergy to cow’s milk: the DREAM RCT Synopsis (The DREAM study)

Guibas G, Brayshaw E, Brown M et al. Efficacy Mech Eval 2026. https://doi.org/10.3310/GJGG7715 Background Immunoglobulin E-mediated (imme...
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments

Vieira RJ, Sousa-Pinto B, Bousquet J et al. Allergy. 2026 Mar 24. doi: 10.1111/all.70305. Abstract Background: Oral and ocular medication...

Twitter

Tweets by @Aller_MD

Interesting Links

World Allergy Organization
Latin American Society of Allergy, Asthma & Immunology
Interasma
European Academy of Allergy & Immunology
American College of Allergy, Asthma & Immunology
American Academy of Allergy, Astma & Immunology
TRIP Database
Ga2len

Juan Carlos Ivancevich, MD. Powered by Blogger.